Market Cap : 7.52 B | Enterprise Value : 6.47 B | PE Ratio : | PB Ratio : 8.87 |
---|
NAS:IONS has been successfully added to your Stock Email Alerts list.
You can manage your stock email alerts here.
NAS:IONS has been removed from your Stock Email Alerts list.
Please enter Portfolio Name for new portfolio.
YoY Rev. per Sh. Growth is the percentage change of Revenue per Share over the past twelve months. Ionis Pharmaceuticals's YoY Rev. per Sh. Growth for the quarter that ended in Dec. 2020 was -39.92%.
Ionis Pharmaceuticals's Revenue per Share for the three months ended in Dec. 2020 was $2.07.
* All numbers are in millions except for per share data and ratio. All numbers are in their local exchange's currency.
YoY Rev. per Sh. Growth is the percentage change of Revenue per Share over the past twelve months.
Ionis Pharmaceuticals's YoY Rev. per Sh. Growth for the fiscal year that ended in Dec. 2020 is calculated as:
YoY Rev. per Sh. Growth (A: Dec. 2020 ) | |||||
= | (Revenue per Share (A: Dec. 2020 ) | - | Revenue per Share (A: Dec. 2019 )) | / | | Revenue per Share (A: Dec. 2019 ) | |
= | (5.224 | - | 7.857) | / | | 7.857 | |
= | -33.51 % |
Ionis Pharmaceuticals's YoY Rev. per Sh. Growth for the quarter that ended in Dec. 2020 is calculated as:
YoY Rev. per Sh. Growth (Q: Dec. 2020 ) | |||||
= | (Revenue per Share (Q: Dec. 2020 ) | - | Revenue per Share (Q: Dec. 2019 )) | / | | Revenue per Share (Q: Dec. 2019 )) | |
= | (2.074 | - | 3.452) | / | | 3.452 | |
= | -39.92 % |
* All numbers are in millions except for per share data and ratio. All numbers are in their local exchange's currency.
No Headline